Is this your firm? Get featured or correct your listing →
At a glance
Sectoral Asset Management appears in 3 funding rounds tracked by ValueAddVC since 2026. Its most frequent sector in these rounds is Health & Biotech, and its most recent tracked deal was HighLife's $90M Growth round (Sep 22, 2026). It co-invests most often with Forbion and TPG.
Strategy
Recent changes
- Sep 22, 2026Sep 22, 2026Invested in HighLife (Growth, $90M) GlobeNewswire
- Sep 16, 2026Sep 16, 2026Invested in Sling Therapeutics (Series C, $123M) BioSpace
Portfolio
3 totalRecent Investment Activity
3Track record: led 0 and participated in 3 of 3 tracked venture rounds · 2 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | HighLife | Growth | Participated | $90M | — | Pulse story | |
| Sep 16, 2026 | Sling Therapeutics | Series C | Participated | $123M | — | Pulse story | |
| Sling Therapeutics | Series B | Participated | $123M | — | Fierce Biotech |
Sector / Stage Activity
Co-Investors
9Similar Firms
overlapping sector, stage or regionLatest Pulse
- Sep 22, 2026HighLife Raises $90M For US Heart Valve StudyHighLife raised more than $90 million co-led by Andera Partners and Sofinnova Partners to fund a US pivotal study of its transcatheter mitral valve system and accelerate its European commercial rollout.→
- Sep 16, 2026Sling Banks $123M To Push Oral Thyroid Eye Disease PillSling Therapeutics closed a $123 million Series C led by Forbion to fund a Phase 3 trial of linsitinib, an oral pill positioned as a more convenient alternative to injectable treatments for thyroid eye disease.→
Sectoral Asset Management FAQ
What companies has Sectoral Asset Management invested in?
Sectoral Asset Management's portfolio includes HighLife, Sling Therapeutics, Apnimed.
Who does Sectoral Asset Management co-invest with most?
In the rounds Value Add tracks, Sectoral Asset Management most often invests alongside Alpha Wave Global (1 shared deal), Columbia Management (1 shared deal), Columbia Seligman Technology and Information Fund (1 shared deal), Forbion (1 shared deal), Morningside Ventures (1 shared deal).
Sources & methodologyshow
- GlobeNewswireprimary source1 fact
- Fierce Biotechmajor outlet1 fact
- BioSpaceresearch database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.